Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Water and Wastewater
- Agriculture
- Health and Safety
- Monitoring and Testing
- Environmental
- Manufacturing, Other
- Food and Beverage
- Mining
- Automobile & Ground Transport
- Aerospace & Air Transport
- Waste and Recycling
- Air and Climate
- Defense
- Electronics and Computers
- Domestic
- Forestry & Wood
- Household Appliances
- Real Estate
- Oil, Gas & Refineries
- Government
- Energy
- Construction & Construction Materials
Drug Resistant Suppliers & Manufacturers
84 companies found
based inBozeman, MONTANA (USA)
Microbion is a clinical-stage pharmaceutical company developing a novel class of compounds for the treatment of difficult-to-treat infections, including chronic infections and antibiotic-resistant infections. Microbion is dedicated to developing ...
Microbion has two Phase 2 clinical programs in diabetic foot ulcer infection and orthopedic implant infection. In addition, preclinical programs are under development for multiple therapeutic indications, including the treatment of serious ...
based inSydney, AUSTRALIA
Nanosonics is an Australian infection prevention company that has successfully developed and commercialised a unique automated disinfection technology, trophon, representing the first major innovation in high level disinfection for ultrasound probes ...
Every day, 82,000 patients are protected from the risk of cross contamination because the ultrasound probe has been high-level disinfected with the trophon ...
based inMont-Saint-Guibert, BELGIUM
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution platform is based on the Genio® system, a CE-Mark validated, ...
Genio is the disruptive sleep apnea solution for patients who suffer from moderate to severe Obstructive Sleep Apnea or OSA. Genio is the world’s first and unique battery-free, leadless, full body MR conditional and minimally invasive ...
based inTel-Aviv, ISRAEL
RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of ...
TALICIA is an oral, all-in-one capsule containing omeprazole, amoxicillin, and rifabutin that is indicated for the treatment of Helicobacter pylori infection in ...
based inNew York, NEW YORK (USA)
ENB is developing platform oncology molecules to unlock the full therapeutic potential of immune-based cancer therapies. We are developing small molecules that turn off a common “switch” that activates critical pro-cancer components of the TME: the ...
based inLeverkusen, GERMANY
Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to help people and planet thrive by supporting efforts to address the unprecedented global challenges ...
Traditionally, many small molecule drugs follow the same basic mechanism of action to treat diseases: They inhibit the function of a target protein that has an active role in a disease. To do so, they require a tractable active binding site to ...
based inSan Francisco, CALIFORNIA (USA)
Motic Digital Pathology addresses the growing global pathology care gap by making digital medicine approachable for hospitals, labs, and doctors everywhere. We promote adoption of telepathology through our innovative, cost-effective solutions ...
based inMountain View, CALIFORNIA (USA)
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a ...
based inSalt Lake City, UTAH (USA)
Light Line Medical, Inc.’s patented visible-light platform technology is an infection prevention game-changer, destined to create a massive global shift in how the world prevents and treats healthcare-associated infections. The CDC reported that ...
based inHamburg, GERMANY
Indivumed GmbH was founded in 2002 by leading scientists with a drive to revolutionize cancer treatment through individualized therapy. As a physician-led, integrated global oncology company our experts leverage the world’s premier multi-omics ...
The outcome of your research is directly linked to the quality of the used biospecimen. In order to reflect the molecular reality, the biospecimen quality benefits from our standardized sampling by Indivumed study nurses and Indivumed trained ...
based inSan Diego, CALIFORNIA (USA)
Stelvio Oncology utilizes an image based method of epigenetic markers to develop predictive diagnostics and novel therapeutics for cancer. Stelvio Oncology is developing a personalized approach to glioblastoma treatment. Our team has core ...
based inXiamen City,, CHINA
Found in 1999, Huiying Animal Health Co. Ltd. is located in the beautiful garden city—Xiamen, with subsidiary corporations including Xiamen Huiying Animal Science Tech. Co. Ltd., Xiamen Huiying Animal Pharmaceutical Co. Ltd., Xiamen Jundingxin ...
based inSunnyvale, CALIFORNIA (USA)
Over a decade ago, Cepheid set the standard for innovation in automated molecular diagnostics — and we’ve never looked back. Today, even with the largest installed base of any molecular platform, Cepheid is constantly innovating and evolving its ...
On-demand molecular testing — an ideal solution: Accurate molecular detection of MRSA or SA from a gram-positive blood culture sample in about an hour; Simple test protocol can be run on all shifts to provide results around-the-clock; Provides ...
based inSan Diego, CALIFORNIA (USA)
CureMatch, Inc. is a San Diego-based digital health company focused on personalized medicine and combination therapy in oncology. CureMatch’s Decision Support System guides oncologists in the selection of cancer drugs that are customized for ...
CureMatch provides a scored and ranked listing of the most well-adapted personalized medicine treatment options. The comprehensive analysis considers commonly used treatments, as well as targeted therapy, immunotherapy, hormone therapy, and newly ...
based inNorwich, UNITED KINGDOM
We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...
Proprietary nanoparticles deliver an oligonucleotide inside the bacterial pathogen. The oligonucleotide acts as a Transcription Factor Decoy (TFD): it contains the binding site of a transcription factor that controls a large set of genes required ...
based inNorth Ryde, AUSTRALIA
Biotron Limited (Biotron) is a clinical stage publicly listed Australian Biotechnology Company based in Sydney, Australia. The company is developing and commercialising a novel small molecule approach that has the potential to treat a number of ...
Biotron is developing novel small molecule antiviral therapeutics targeting a range of viruses including Hepatitis C virus (HCV) and ...
based in, NEW YORK (USA)
Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. Every day, Pfizer colleagues work across developed and emerging ...
Sterile Bacitracin, USP is an antibiotic for intramuscular administration. Bacitracin is derived from cultures of Bacillus subtilis (Tracey). It is a white to pale buff, hygroscopic powder, odorless or having a slight odor. It is freely soluble in ...
based inParis, FRANCE
CHROMagar™ was incorporated in 1993 by the inventor, and pioneer in chromogenic culture media technology, Dr Alain Rambach. Established in the heart of Paris (France) close to the famous Pasteur Institute where Dr Rambach began his research career, ...
Performance: β-Lactamase production (ESBL, AmpC, carbapenemase) is the most common mechanism of β-lactam drug resistance in Gram negative bacteria. Each of the involved mechanisms can be plasmid-encoded ...
based inSpokane, WASHINGTON (USA)
IMS has pioneered and patented technologies aimed at preventing medical device infections and treating and preventing infections associated with complex wounds. We have also developed performance coatings for various applications including ...
Our platform No. 2 antimicrobial additives can be broadly applicable across medical, consumer and industrial markets. A wide variety of derivatives have been synthesized. In the medical device space silver (Ag+) and quaternary ammonium compounds ...